Radoslav Goldman Selected Research

Radoslav Goldman Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 01/2003
16	Liver Diseases (Liver Disease) 12/2021 - 01/2008
14	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 01/2006
13	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022 - 09/2012
9	Fibrosis (Cirrhosis) 10/2018 - 02/2008
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2011
4	Carcinogenesis 07/2016 - 01/2003
3	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2010
3	Hepatitis C 01/2017 - 03/2009
3	Virus Diseases (Viral Diseases) 01/2015 - 02/2008
3	Lung Neoplasms (Lung Cancer) 01/2014 - 11/2003
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
2	Infections 01/2020 - 10/2007
2	Liver Neoplasms (Liver Cancer) 02/2012 - 09/2009
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Carcinoma (Carcinomatosis) 07/2016
1	Dengue (Dengue Fever) 01/2015
1	Inflammation (Inflammations) 01/2014
1	Colonic Neoplasms (Colon Cancer) 05/2009

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
15	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2005
14	Polysaccharides (Glycans)IBA 12/2021 - 01/2008
9	Peptides (Polypeptides)IBA 01/2017 - 05/2006
6	GlycopeptidesIBA 12/2021 - 05/2013
6	Glycoproteins (Glycoprotein)IBA 12/2018 - 01/2010
4	HemopexinIBA 10/2018 - 11/2014
3	Glycoside Hydrolases (Endoglycosidases)IBA 12/2021 - 05/2013
3	NucleotidesIBA 01/2021 - 01/2003
2	Indicators and Reagents (Reagents)IBA 03/2022 - 11/2014
2	Blood Proteins (Serum Proteins)IBA 12/2021 - 10/2018
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2020 - 07/2016
2	Messenger RNA (mRNA)IBA 01/2020 - 09/2014
2	SulfatasesIBA 01/2020 - 07/2016
2	ProteomeIBA 01/2019 - 02/2012
2	Immunoglobulins (Immunoglobulin)IBA 10/2018 - 02/2015
2	Biological ProductsIBA 10/2018 - 01/2010
2	Immunoglobulin G (IgG)IBA 10/2016 - 02/2015
2	IonsIBA 02/2015 - 09/2012
2	Pharmaceutical PreparationsIBA 01/2015 - 01/2010
2	Estrogens (Estrogen)FDA Link 01/2014 - 04/2011
2	AndrogensIBA 01/2014 - 04/2011
2	phenethyl isothiocyanate (PEITC)IBA 01/2014 - 07/2007
2	HaptoglobinsIBA 05/2013 - 05/2013
2	DNA (Deoxyribonucleic Acid)IBA 06/2008 - 01/2003
2	MutagensIBA 01/2008 - 01/2003
1	AntigensIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 12/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	EnzymesIBA 01/2020
1	CholesterolIBA 01/2019
1	HDL LipoproteinsIBA 01/2019
1	HDL CholesterolIBA 01/2019
1	N-lignocerylgalactosylsphingosineIBA 12/2018
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 10/2018
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 10/2018
1	ClusterinIBA 10/2018
1	VitronectinIBA 10/2018
1	Transferrin (beta 2 Transferrin)IBA 10/2018
1	LumicanIBA 10/2018
1	Ceruloplasmin (Ferroxidase)IBA 10/2018
1	Sex Hormone-Binding GlobulinIBA 01/2018
1	hydronium ionIBA 02/2015
1	Heparitin Sulfate (Heparan Sulfate)IBA 02/2015
1	Monoclonal AntibodiesIBA 02/2015
1	VaccinesIBA 01/2015
1	Complement Factor H (Factor H)IBA 11/2014
1	Alkynes (Acetylenes)IBA 01/2014
1	LigandsIBA 01/2014
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2014
1	IsoenzymesIBA 01/2014
1	Tumor Biomarkers (Tumor Markers)IBA 10/2013
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2012
1	SphingolipidsIBA 09/2012
1	IsotopesIBA 09/2012
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 09/2012
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 09/2012
1	OligosaccharidesIBA 08/2011
1	16-ketoestradiolIBA 04/2011
1	complement C3fIBA 01/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010
1	Complement System Proteins (Complement)IBA 01/2010
1	Factor XIII (Coagulation Factor XIII)IBA 01/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2010
1	ZyxinIBA 01/2010
1	biliverdin diglucuronideIBA 01/2010
1	Docosahexaenoic AcidsIBA 05/2009
1	Acrolein (Aqualin)IBA 05/2009
1	DNA AdductsIBA 05/2009
1	SmokeIBA 06/2008
1	sulforaphaneIBA 07/2007
1	AntibodiesIBA 08/2005
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 11/2003

Therapy/Procedure

1	Therapeutics 01/2022
1	Immunotherapy 01/2021
1	Glycemic Control 01/2019
1	Lasers (Laser) 03/2009